| Non-ionic surfactant based vesicles (niosomes) in drug delivery IF Uchegbu, SP Vyas International journal of pharmaceutics 172 (1-2), 33-70, 1998 | 1338 | 1998 |
| Dendrimers in gene delivery C Dufès, IF Uchegbu, AG Schätzlein Advanced drug delivery reviews 57 (15), 2177-2202, 2005 | 1258 | 2005 |
| Gene delivery with synthetic (non viral) carriers MD Brown, AG Schätzlein, IF Uchegbu International Journal of Pharmaceutics 229 (1-2), 1-21, 2001 | 578 | 2001 |
| Non-ionic surfactant vesicles (niosomes): physical and pharmaceutical chemistry IF Uchegbu, AT Florence Advances in colloid and interface science 58 (1), 1-55, 1995 | 553 | 1995 |
| The lower-generation polypropylenimine dendrimers are effective gene-transfer agents BH Zinselmeyer, SP Mackay, AG Schatzlein, IF Uchegbu Pharmaceutical research 19, 960-967, 2002 | 432 | 2002 |
| Amphiphilic poly (l-amino acids)—new materials for drug delivery A Lalatsa, AG Schätzlein, M Mazza, TBH Le, IF Uchegbu Journal of Controlled Release 161 (2), 523-536, 2012 | 245 | 2012 |
| Preliminary characterization of novel amino acid based polymeric vesicles as gene and drug delivery agents MD Brown, A Schätzlein, A Brownlie, V Jack, W Wang, L Tetley, AI Gray, ... Bioconjugate chemistry 11 (6), 880-891, 2000 | 216 | 2000 |
| The release of model macromolecules may be controlled by the hydrophobicity of palmitoyl glycol chitosan hydrogels L Martin, CG Wilson, F Koosha, L Tetley, AI Gray, S Senel, IF Uchegbu Journal of controlled release 80 (1-3), 87-100, 2002 | 214 | 2002 |
| Polymeric chitosan-based vesicles for drug delivery IF Uchegbu, AG Schätzlein, L Tetley, AI Gray, J Sludden, S Siddique, ... Journal of pharmacy and pharmacology 50 (5), 453-458, 1998 | 205 | 1998 |
| Polymers in drug delivery IF Uchegbu, AG Schatzlein CRC Press, 2006 | 193 | 2006 |
| Preferential liver gene expression with polypropylenimine dendrimers AG Schatzlein, BH Zinselmeyer, A Elouzi, C Dufes, YTA Chim, CJ Roberts, ... Journal of Controlled Release 101 (1-3), 247-258, 2005 | 190 | 2005 |
| The effect of processing variables on the physical characteristics of non-ionic surfactant vesicles (niosomes) formed from a hexadecyl diglycerol ether P Arunothayanun, MS Bernard, DQM Craig, IF Uchegbu, AT Florence International journal of pharmaceutics 201 (1), 7-14, 2000 | 187 | 2000 |
| Carbohydrate-based micelle clusters which enhance hydrophobic drug bioavailability by up to 1 order of magnitude X Qu, VV Khutoryanskiy, A Stewart, S Rahman, ... Biomacromolecules 7 (12), 3452-3459, 2006 | 182 | 2006 |
| Sustained buccal delivery of the hydrophobic drug denbufylline using physically cross-linked palmitoyl glycol chitosan hydrogels L Martin, CG Wilson, F Koosha, IF Uchegbu European journal of pharmaceutics and biopharmaceutics 55 (1), 35-45, 2003 | 174 | 2003 |
| Synthetic anticancer gene medicine exploits intrinsic antitumor activity of cationic vector to cure established tumors C Dufes, WN Keith, A Bilsland, I Proutski, IF Uchegbu, AG Schätzlein Cancer research 65 (18), 8079-8084, 2005 | 172 | 2005 |
| Nose-to-brain delivery Z Wang, G Xiong, WC Tsang, AG Schätzlein, IF Uchegbu Journal of Pharmacology and Experimental Therapeutics 370 (3), 593-601, 2019 | 168 | 2019 |
| PEI-based vesicle-polymer hybrid gene delivery system with improved biocompatibility A Brownlie, IF Uchegbu, AG Schätzlein International journal of pharmaceutics 274 (1-2), 41-52, 2004 | 168 | 2004 |
| Quaternary ammonium palmitoyl glycol chitosan—a new polysoap for drug delivery IF Uchegbu, L Sadiq, M Arastoo, AI Gray, W Wang, RD Waigh, ... International journal of pharmaceutics 224 (1-2), 185-199, 2001 | 164 | 2001 |
| Strategies to deliver peptide drugs to the brain A Lalatsa, AG Schatzlein, IF Uchegbu Molecular pharmaceutics 11 (4), 1081-1093, 2014 | 161 | 2014 |
| Anticancer drug delivery with transferrin targeted polymeric chitosan vesicles C Dufes, JM Muller, W Couet, JC Olivier, IF Uchegbu, AG Schätzlein Pharmaceutical research 21, 101-107, 2004 | 161 | 2004 |
